NCT07579013 Effect of Postural Drainage With or Without Thoracic Squeezing on O2 and Respiratory Rate in Infant With RDS.
| NCT ID | NCT07579013 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Respiratory Distress Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 14 participants |
| Start Date | 2025-10-28 |
| Primary Completion | 2026-07-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 14 participants in total. It began in 2025-10-28 with a primary completion date of 2026-07-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigated whether adding thoracic squeezing to postural drainage improves immediate respiratory outcomes in preterm infants with Respiratory Distress Syndrome (RDS). Over nine months, 14 preterm infants (all born via cesarean section) were randomly assigned to two groups. The control group received standard care with postural drainage, while the experimental group received postural drainage combined with the lung squeezing technique (LST), which applies gentle chest pressure to enhance airflow and mucus clearance. Infants with genetic disorders, congenital anomalies, or on neurotropic drugs were excluded. Oxygen saturation and respiratory distress were measured using the Oxygen Saturation Index and Silverman-Anderson Scale, with data analyzed in SPSS. The study aimed to determine whether combining thoracic squeezing with postural drainage has a greater immediate effect on improving oxygen levels and reducing respiratory distress compared to postural drainage alone.
Eligibility Criteria
Inclusion Criteria: * ● Children diagnosed with RDS. * Pre term infants. Birth history with c- section. * No congenital malformation. Exclusion Criteria: * ● Under treatment with neurotropic drugs. * Respiratory and cardiac congenital anamolies. * Genetic disorder. * Interventricular hemorrhage or seizures.
Contact & Investigator
NIMRA MUBASHAR, MS-PT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07579013 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, up to 2 Months, studying Respiratory Distress Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07579013 currently recruiting?
Yes, NCT07579013 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07579013 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07579013 clinical trial?
NCT07579013 is sponsored by Riphah International University. The principal investigator is NIMRA MUBASHAR, MS-PT at Riphah International University. The trial plans to enroll 14 participants.